Menlo Ventures

Credit Sesame, Inc. operates a credit and loan management platform designed to simplify and automate consumer credit management. Founded in 2006 and headquartered in Mountain View, California, with an additional office in San Francisco, the company provides tools that allow users to analyze their loans, credit scores, home mortgages, and credit card debts. Credit Sesame offers free access to credit score monitoring, credit reports, and identity theft protection. It also delivers personalized recommendations for refinancing and managing various financial products, including personal loans, home loans, and credit cards. By integrating these services, Credit Sesame aims to help consumers enhance their financial wellness and improve their credit and spending power.

nLIGHT designs, manufactures, and markets fiber lasers and related laser systems for industrial, microfabrication, medical, and defense applications. The company operates in two segments: Laser Products, which includes semiconductor lasers and fiber lasers, and Advanced Development, which derives revenue from research and development contracts. It also produces optical fiber products. nLIGHT serves original equipment manufacturers primarily through a direct sales force in the United States, China, South Korea, and Finland, complemented by independent sales representatives and distributors in Asia and Europe. Headquartered in Vancouver, Washington, the company was founded in 2000. Its products and technologies address a range of end markets, including industrial technology, microfabrication, aerospace and defense, and medical, with a focus on diode and fiber laser platforms.

Nexenta Systems, Inc. is a leading provider of software-defined storage solutions, specializing in open-source-driven technology. Founded in 2005 and headquartered in San Jose, California, the company offers a range of products designed to optimize storage infrastructure for enterprise applications. Its flagship platform, NexentaStor, delivers both file and block storage services, while NexentaCloud enhances virtual desktop infrastructure deployments. The NexentaEdge object storage platform allows users to access data without needing to know its physical location. Additionally, NexentaFusion provides analytics and orchestration software for managing complex compute systems and data stores. Nexenta's solutions are designed to support various applications, clouds, and hardware platforms, enabling organizations to avoid vendor lock-in and adopt flexible, scalable storage strategies. The company has established strategic partnerships with numerous technology leaders and serves a diverse global customer base. As of May 2019, Nexenta operates as a subsidiary of DataDirect Networks, Inc.

Roku is a TV streaming platform provider with platform and player segments. The platform enables discovery and access to movies, TV episodes, live sports, music and news, and includes advertising products such as video ads, brand sponsorships, and audience development campaigns. Roku also sells TVs branded Roku TV, licenses its operating system, and offers streaming media players and accessories, along with subscription and billing services. It partners with retailers and device manufacturers for co-branded devices and sells directly to consumers, with a global reach that includes millions of households. The Roku Channel provides free, ad-supported on-demand and live programming. The Roku OS powers devices and licensed televisions, and the company earns revenue from devices, licensing and advertising. Founded in 2002 and headquartered in Los Gatos, California, Roku serves more than 90 million streaming households and logged about 127 billion streaming hours in 2024, reflecting its position as a leading streaming platform in the United States.

Broncus Technologies is a medical technology company specializing in minimally-invasive devices for treating emphysema and other lung diseases. Its flagship product, Exhale, employs Airway Bypass therapy, potentially the first minimally-invasive treatment for severe homogeneous emphysema. Broncus is currently enrolling patients worldwide in its pivotal EASE Trial.